Close Menu

reagents

The Spanish research products firm has agreed with Kilpest to establish an India-based joint venture to supply the South Asian health and agriculture research communities.

The CEO of Swift, which launched in January and develops molecular biology reagents, said the money will help accelerate product development and customer testing.

Meridian has acquired the reagents maker, adding complementary products to its life science business. The firm also reported an 11 percent decline in Q3 revenues.

The acquisition will add reagents for nucleic acid and protein purification, restriction and modifying enzymes, and other life science research and diagnostic tools to Thermo's Analytical Technologies portfolio.

The dispute stems from a licensing agreement in 2005 covering reagent patents held by Abaxis. Cepheid filed a countersuit yesterday, claiming it has not breached the license and asking the court to declare Abaxis' patents invalid.

Based in Ontario with principal operations in Lithuania, Fermentas offers reagents for nucleic acid and protein purification, restriction and modifying enzymes, and various PCR products.

TriLink will provide ETS Laboratories with its CleanAmp reagents for PCR assays testing for wine spoilers.

Finnzymes had $20 million in revenues in 2009 and makes reagents, consumables, kits, and instruments for molecular biology applications.

The company will make and sell a Manchester-developed diagnostic reagent technology through an agreement that includes a research collaboration.

While revenues fell short of analysts' expectations for the quarter, the legacy Invitrogen business reported 7 percent organic revenue growth. The Q4 revenue numbers also do not include mass spec sales, which are now accounted for as an equity investment. In addition, company officials predicted 2009 organic revenue growth in the low single-digits.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.